UBC

Get to know UBC’s Dobrochna Dolicka, PhD! As a Safety Scientist, she authors periodic safety reports and conducts other signal management activities while supporting the development of automated PV services. Read her full bio at https://hubs.li/Q03bLgr90 #PatientsFirst #Pharmacovigilance #PatientSafety #DrugSafety

Supporting orphan drugs and populations is a central part of what we do at UBC. Join us at the World Orphan Drug Congress for fresh ideas, proven strategies, and good conversation. Set up a time to talk with us: https://hubs.li/Q03gpmDj0 #PatientsFirst #WorldOrphanUSA #OrphanDrug

In a few weeks, the Asembia AXS25 Summit will bring together leaders of the specialty pharmacy industry, and we can't wait to join them! Our team will be available to meet prior to the event and onsite to discuss how our collaborative solutions can support your product across its lifecycle — make your appointment now: https://hubs.li/Q03fYK4Y0 #PatientsFirst #Asembia25

Meet Judy Lytle, PhD, MBEE, PMP, UBC’s Executive Director of Study Solutions. Judy’s 15+ years of experience driving and utilizing RWE helps UBC design and operationalize differentiated study design and evidence generation solutions. Get her full bio at https://hubs.li/Q03bLHRh0 #PatientsFirst #PatientAccess #PatientServices #Pharma

Interest in using alternative treatments, such as psychedelics (e.g., psilocybin, MDMA, LSD, DMT), for mental health disorders has increased in recent years. Learn about the evidence for these treatments, and considerations for future studies in UBC’s blog: https://hubs.li/Q03ggVVf0 #PatientsFirst #Psychedelics #RiskManagement #REMS

We're thrilled to be on-site alongside the knowledgeable neurologists and neuroscience professionals at AAN. Don't miss your chance for a conversation with our Evidence Development and Safety & Risk Management teams: https://hubs.li/Q03dMChp0 #AANAM #PatientsFirst

Pharmacovigilance (PV) is more critical than ever, as life sciences companies navigate rising adverse event volumes, increasingly complex global regulations, and the ethical implications of AI driven safety monitoring. The demand for proactive, technology-enabled PV solutions has never been higher. That’s why we’re proud to share that 𝗨𝗕𝗖 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗻𝗮𝗺𝗲𝗱 𝗮 𝘁𝗼𝗽-𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗽𝗿𝗼𝘃𝗶𝗱𝗲𝗿 in the 𝗘𝘃𝗲𝗿𝗲𝘀𝘁 𝗚𝗿𝗼𝘂𝗽 𝗣𝗩 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗣𝗘𝗔𝗞 𝗠𝗮𝘁𝗿𝗶𝘅® 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁—a testament to our deep expertise, comprehensive compliance capabilities, and investment in cutting-edge technology to enhance patient safety. Looking to elevate your PV strategy? Let’s connect and explore how UBC can support your PV needs: https://hubs.li/Q03f-mrx0 #Pharmacovigilance #PatientSafety #PatientsFirst #EverestGroup

Get to know UBC’s Christopher Henry, PhD! He is a Safety Scientist on our pharmacovigilance team who is also applying his background in AI to enhancing automation within our comprehensive suite of safety solutions. Read his full bio at https://hubs.li/Q03bLbry0 #PatientsFirst #Pharmacovigilance #PatientSafety #DrugSafety

Meet Judy Lytle, PhD, MBEE, PMP, UBC’s Executive Director of Study Solutions. Judy’s 15+ years of experience driving and utilizing RWE helps UBC design and operationalize differentiated study design and evidence generation solutions. Get her full bio at https://hubs.li/Q03bLzjd0 #PatientsFirst #PatientAccess #PatientServices #Pharma

In just a few short days, we'll be in San Diego for AAN! Schedule a meeting to learn about expert-driven real-world evidence tailored to specialty patient populations, and safety & risk management solutions that build confidence for prescribers: https://hubs.li/Q03dMx9s0 #AANAM #PatientsFirst